Rebecca K. Rowntree
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, Chemical Synthesis and Analysis, CAR-T cell therapy research
Most-Cited Works
- → LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity(2022)357 cited
- → The Phenotypic Consequences of CFTR Mutations(2003)331 cited
- → X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells(2008)300 cited
- → Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity(2019)185 cited
- → Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy(2021)161 cited
- → Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties(2021)144 cited
- → Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)(2019)104 cited
- → Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis(2012)82 cited
- → Higher order chromatin structure at the X-inactivation center via looping DNA(2008)76 cited
- → Identification of Developmentally Specific Enhancers for Tsix in the Regulation of X Chromosome Inactivation(2005)75 cited